Ian Ahnfelt-Ronne, Corporate Vice President , Novo Nordisk A/S - FEATURED

Juan Carlos Lopez-Talavera, Vice President, Global Development Lead, Global Development & Medical Affairs, Research and Development, Bristol-Myers Squibb Company - FEATURED

Tomas Mustelin, Vice President, Research, Respiratory, Inflammatory, and Autoimmune Diseases, MedImmune - FEATURED

Joost J. Oppenheim, Chief, Laboratory of Molecular Immunoregulation, NIH, NCI - FEATURED

Ian Ahnfelt-Ronne, Corporate Vice President, Novo Nordisk A/S - FEATURED

Steven J. Bensinger, Assistant Professor, Institute for Molecular Medicine, UCLA

Raymond Donnelly, Senior Investigator, CBER Research, Office of Therapeutics Research and Review, Food and Drug Administration

Scott K. Durum, Chief, Section of Cytokines and Immunity, NIH, NCI

Grant Gallagher, Managing Director, and Head of Genetic Immunology, HUMIGEN, the Institute for Genetic Immunology

Ru Gunawardane, Sr. Scientist, Amgen

Arthur A. Hurwitz, Principal Investigator, Tumor Immunity and Tolerance Section, Laboratory of Molecular Immunoregulation, Cancer and Inflammation Program, Frederick National Laboratory for Cancer Research, CCR, NCI, NIH

Xiaoxia Li, Professor, Immunology, Lerner Research Institute（NB30）, The Cleveland Clinic Foundation

Nicholas W. Lukacs, Professor of Pathology, Assistant Dean for Faculty Affairs, University of Michigan Medical School

Christopher T. Migliaccio, Research Assistant Professor of Immunology, University of Montana

Martin Oft, Chief Executive Officer, Targenics

Amanda Proudfoot, Principal Scientist, Immunology, Merck Serono Geneva Research Centre

Carl D. Richards, Professor, Pathology and Molecular Medicine, McMaster Unversity

Robert C. Rickert, Professor and Director, Program on Inflammatory Diseases, Infectious and Inflammatory Disease Center, Sanford-Burnham Medical Research Institute

Shahram Salek-Ardakani, Associate Professor, Pathology, Immunology and Laboratory of Medicine, University of Florida

William Stohl, Professor of Medicine, Chief, Division of Rheumatology, Keck School of Medicine of USC

Jennifer Towne, Principal Scientist, Amgen

Domagoj Vucic, Senior Scientist, Early Discovery Biochemistry, Genentech

Ji Ming Wang, Senior Investigator, Laboratory of Molecular Immunoregulation, Cancer and Inflammation Program, Center for Cancer, Research, Frederick National Laboratory for Cancer, Research, National Cancer Institute

Jon Wigginton, Executive Medical Director, Bristol-Myers Squibb

Howard A. Young, Principal Investigator & Deputy Lab Chief, Laboratory of Experimental Immunology, Cancer and Inflammation Program, Center for Cancer Research, Frederick National Laboratory for Cancer Research, CCR, NCI, NIH

Hua Yu, Associate Chair and Professor, Cancer Immunotherapeutics & Tumor Immunology, Beckman Research Institute at City of Hope Comprehensive Cancer Center

Timothy S. Zheng, Principal Scientist, R&D - Immunology, Biogen Idec

...and more!

For an updated speaker list, click here.
Register today and save 20% before Nov 30th!
Sign up 3 people for the price of 2! Use discount code rcdvb.